[1] |
徐海萍, 高继勇, 宋凤娟, 等.
骨髓纤维化74例临床分析[J]. 白血病·淋巴瘤白血病·淋巴瘤, 2006, 15(5): 369-371.
doi: 10.3760/cma.j.issn.1009-9921.2006.05.018 Xu HP, Gao JY, Song FJ, et al. Clinical analysis of 74 cases of myelofibrosis[J]. J Leuk LymphomaJ Leuk Lymphoma, 2006, 15(5): 369-371. doi: 10.3760/cma.j.issn.1009-9921.2006.05.018 |
[2] |
Balkan C, Ersoy B, Nese N.
Myelofibrosis associated with severe vitamin D deficiency rickets[J]. J Int Med ResJ Int Med Res, 2005, 33(3): 356-359.
doi: 10.1177/147323000503300311 |
[3] |
Butt YM, Chen WN.
Myelofibrosis secondary to renal osteodystrophy[J]. BloodBlood, 2016, 128(16): 2104-.
doi: 10.1182/blood-2016-07-726182 |
[4] |
Lim DJ, Oh EJ, Park CW, et al.
Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism[J]. Int J Lab HematolInt J Lab Hematol, 2007, 29(6): 464-468.
doi: 10.1111/j.1365-2257.2006.00877.x |
[5] |
Del Porto F, Tatarelli C, Di Napoli A, et al.
Systemic lupus erythematosus and myelofibrosis: a case report and revision of literature[J]. Leuk Res RepLeuk Res Rep, 2018, 9: 58-64.
doi: 10.1016/j.lrr.2018.04.004 |
[6] |
Valent P, Horny HP, Escribano L, et al.
Diagnostic criteria and classification of mastocytosis: a consensus proposal[J]. Leuk ResLeuk Res, 2001, 25(7): 603-625.
doi: 10.1016/S0145-2126(01)00038-8 |
[7] |
Ozdemir D, Dagdelen S, Erbas T.
Systemic mastocytosis[J]. Am J Med SciAm J Med Sci, 2011, 342(5): 409-415.
doi: 10.1097/MAJ.0b013e3182121131 |
[8] |
Fritz J, Fishman EK, Carrino JA, et al.
Advanced imaging of skeletal manifestations of systemic mastocytosis[J]. Skeletal RadiolSkeletal Radiol, 2012, 41(8): 887-897.
doi: 10.1007/s00256-012-1374-9 |
[9] |
Djelbani-Ahmed S, Chandesris MO, Mekinian A, et al.
FDG-PET/CT findings in systemic mastocytosis: a French multicentre study[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2015, 42(13): 2013-2020.
doi: 10.1007/s00259-015-3117-3 |